WithdrawnPHASE2INTERVENTIONAL
A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA)
- Sponsor:
- Fox Chase Cancer Center
- Conditions:
- Metastatic Urothelial Carcinoma
- Started:
- Sep 2023
NCT06050954
Human trials
Where longevity science meets human data: registered trials of aging interventions, pulled daily from ClinicalTrials.gov. Status, phase, sponsor, and enrollment for each.
NCT06050954
NCT06113484
NCT05342896
NCT03620539
NCT06105320
NCT05945160
NCT03071835
NCT06073925
NCT05839743
NCT06057077
NCT05236127
NCT04713852
NCT06038500
NCT06043284
NCT05404022
NCT02310451
NCT05004220
NCT04173728
NCT01186042
NCT06020742
NCT03682523
NCT04258579
NCT06012396
NCT05044299
Literature and preprints via Europe PMC. Trial data from ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine. We store metadata and abstracts and link to every source record. This is educational information, not medical advice.